国际呼吸杂志
國際呼吸雜誌
국제호흡잡지
INTERNATIONAL JOURNAL OF RESPIRATION
2011年
19期
1488-1491
,共4页
调节性T细胞%Th2细胞%支气管哮喘
調節性T細胞%Th2細胞%支氣管哮喘
조절성T세포%Th2세포%지기관효천
Regulatory T cells%Th2 cells%Bronchial asthma
支气管哮喘(简称哮喘)是一种慢性气道炎症性疾病,尤以机体Th2型免疫反应为主要表现,而近年来的大量研究表明调节性T细胞具有抑制Th2型反应的功能.通过对哮喘患者体内的调节性T细胞进行干预,来达到对哮喘的治疗和预防作用,已成为且前哮喘领域研究的热点.
支氣管哮喘(簡稱哮喘)是一種慢性氣道炎癥性疾病,尤以機體Th2型免疫反應為主要錶現,而近年來的大量研究錶明調節性T細胞具有抑製Th2型反應的功能.通過對哮喘患者體內的調節性T細胞進行榦預,來達到對哮喘的治療和預防作用,已成為且前哮喘領域研究的熱點.
지기관효천(간칭효천)시일충만성기도염증성질병,우이궤체Th2형면역반응위주요표현,이근년래적대량연구표명조절성T세포구유억제Th2형반응적공능.통과대효천환자체내적조절성T세포진행간예,래체도대효천적치료화예방작용,이성위차전효천영역연구적열점.
Bronchial asthma is a chronic inflammatory disease of the airway characterized by the Th2 immune response.Recently,a great deal of studies has revealed that regulatory T cells have the ability to suppress Th2 cells.It is the hot spot in the field of bronchial asthma that curing this disease through the intervention to the regulatory T cells in patients.
